Search Results

You are looking at 141 - 150 of 2,748 items for :

  • Refine by Access: All x
Clear All
Full access

Feasibility and Effectiveness of Self-Management Education and Coaching on Patient Activation for Managing Cancer Treatment Toxicities

Doris Howell, Gregory R. Pond, Denise Bryant-Lukosius, Melanie Powis, Patrick T. McGowan, Tutsirai Makuwaza, Vishal Kukreti, Sara Rask, Saidah Hack, and Monika K. Krzyzanowska

also examined preliminary estimates of effectiveness based on patient-reported outcomes. Methods Participants and Recruitment Procedures Ethics approval was obtained from the Ontario Cancer Research Ethics Board for all participating sites

Full access

Identification and Characterization of Avoidable Hospital Admissions in Patients With Lung Cancer

Eric M. Lander, Xuanyi Li, Li-Ching Huang, Amanda S. Cass, Wade T. Iams, Emily A. Skotte, Jennifer G. Whisenant, Robert A. Ramirez, Sally J. York, Travis J. Osterman, Jennifer A. Lewis, Christine M. Lovly, Yu Shyr, and Leora Horn

associated with better outcomes or within patients’ goals of care. Hospital stays in patients with cancer are generally 1.5 days longer and carry a 2-fold higher risk of in-hospital mortality compared with inpatient admissions for other conditions. 6 Most

Full access

Wealth, Health Expenditure, and Cancer: A National Perspective

Jad Chahoud, Adele Semaan, and Alyssa Rieber

Background The health care system in the United States is characterized by an unsustainable increase in spending with penultimate outcomes. 1 , 2 In 2013, the United States spent a total of $2.9 trillion on health, which is approximately $9

Full access

Outpatient Management of Pulmonary Embolism in Cancer: Data on a Prospective Cohort of 138 Consecutive Patients

Carme Font, Alberto Carmona-Bayonas, Aranzazu Fernández-Martinez, Carmen Beato, Andrés Vargas, Pere Gascon, and Remedios Otero

spectrum of PE may vary from sudden life-threatening events to unsuspected radiologic findings on scheduled CT scans. 2 , 3 In several series of patients with acute symptomatic PE, cancer has been identified as a predictor for adverse outcomes. 4 , 5

Full access

Changes in Management of Left-Sided Obstructive Colon Cancer: National Practice and Guideline Implementation

Joyce Valerie Veld, Femke Julie Amelung, Wernard Aat Antoine Borstlap, Emo Eise van Halsema, Esther Catharina Josephina Consten, Peter Derk Siersema, Frank ter Borg, Edwin Silvester van der Zaag, Paul Fockens, Willem Adrianus Bemelman, Jeanin Elise van Hooft, Pieter Job Tanis, and for the Dutch Snapshot Research Group

-term outcomes with additional procedural and long-term surgical and oncologic data through chart review using a web-based tool meeting Dutch privacy regulations by Medical Research Data Management. All 77 Dutch hospitals that register patients in the DCRA were

Full access

Prognostic and Predictive Markers for Patients With Anal Cancer

Emma B. Holliday, Arjun Peddireddy, and Van K. Morris

States. 3 Updated therapeutic approaches for patients with nonmetastatic and metastatic SCCA alike are needed to improve survival outcomes. Concurrent chemoradiation has remained the steadfast treatment for locoregional SCCA for the past half

Full access

Neoadjuvant or Adjuvant Chemotherapy Plus Concurrent CRT Versus Concurrent CRT Alone in the Treatment of Nasopharyngeal Carcinoma: A Study Based on EBV DNA

Li-Ting Liu, Qiu-Yan Chen, Lin-Quan Tang, Shan-Shan Guo, Ling Guo, Hao-Yuan Mo, Yang Li, Qing-Nan Tang, Xue-Song Sun, Yu-Jing Liang, Chong Zhao, Xiang Guo, Chao-Nan Qian, Mu-Sheng Zeng, Jin-Xin Bei, Ming-Huang Hong, Jian-Yong Shao, Ying Sun, Jun Ma, and Hai-Qiang Mai

classifications have markedly different survival outcomes. Infection with Epstein-Barr virus (EBV) is strongly linked to NPC. 13 , 14 Previous studies have shown that patients with high levels of pretreatment plasma EBV DNA have higher rates of distant relapse

Full access

Patient-Reported Symptom Complexity and Acute Care Utilization Among Patients With Cancer: A Population-Based Study Using a Novel Symptom Complexity Algorithm and Observational Data

Linda Watson, Siwei Qi, Claire Link, Andrea DeIure, Arfan Afzal, and Lisa Barbera

associated severity directly impact the care they require, and patients with multiple and/or severe symptoms may need more support or use additional services. A study conducted in Ontario, Canada, used patient-reported outcomes (PROs) data to examine symptoms

Full access

CLO22-048: Treatment Outcomes of Metastatic Urothelial Cancer on Immune Checkpoint Inhibition

Aruni Ghose, John Hayes, Nicolas Omorphos, Nikhil Vasdev, and Sharma Anand

revolutionised the treatment landscape. There exists a dearth of literature of real-world data on clinical trials focussing on immunotherapy treatment outcomes. Methods : Our study population included mUC patients treated at two large North West London Cancer

Full access

Relationship Between Perceptions of Treatment Goals and Psychological Distress in Patients With Advanced Cancer

Areej El-Jawahri, Deborah Forst, Alyssa Fenech, Keri O. Brenner, Amanda L. Jankowski, Lauren Waldman, Isabella Sereno, Ryan Nipp, Joseph A. Greer, Lara Traeger, Vicki Jackson, and Jennifer Temel

their cancer. Figure 1. Patients’ perceptions of their treatment goal and of their oncologist’s goal. Association Between Patients’ Perceptions of Treatment Goals and Patient-Reported Outcomes Figures 2 and 3 depict the rates of clinically significant